A study conducted in several countries and centres to compare the efficacy and safety of an 8 week treatment of patients with high blood pressure with aliskiren 300mg given once daily in fasted state compared to fed state
- Registry ID
- EUCTR2011-005297-36
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE4
- Sponsor
- Novartis Farmaceutica SA
- Start date
- 2012-02-23
- Last update
- 2026-08-16
Conditions
Summary
To evaluate the efficacy of oral aliskiren 300 mg given once daily in reduction of mean 24 hour ambulatory systolic blood pressure (maSBP) from baseline to end of 8 week treatment under light meal (fed) versus fasted conditions in patients with mild to moderate hypertension.
Locations
- , , Slovakia
- , , Italy
- , , Spain
View on source registry